Home / Sweden / Xvivo Perfusion Aktiebolag
Xvivo Perfusion Aktiebolag
Short position disclosed on September 24, 2026.
Evolution of the disclosed total
August 3, 2022 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Marchant MC Ltd | 1.57% | +0.78 pt | May 8, 2026 | |
| JPMorgan Asset Management (UK) Ltd | 1.36% | +0.04 pt | July 16, 2026 | |
| Citadel Advisors LLC | 0.79% | -0.28 pt | September 14, 2026 | |
| ActusRayPartners Limited | 0.60% | new | August 31, 2026 | |
| D E Shaw Co LP | 0.59% | unchanged | April 21, 2026 | |
| AQR Capital Management LLC | 0.50% | new | September 24, 2026 |
In the United States XVIPF (OTC): 430,653 shares sold short on September 15, 2026. FINRA names no fund.
On the other side: the funds that hold Xvivo Perfusion Aktiebolag Titelia
Get the moves on Xvivo Perfusion Aktiebolag by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
Download 166 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.10% of the capital sold short
- Elekta AB (publ) 9.31% of the capital sold short
- JM AB 7.21% of the capital sold short
- Bonesupport Holding AB 6.91% of the capital sold short
- Truecaller AB 6.88% of the capital sold short
- Hemnet Group AB (publ) 5.63% of the capital sold short
- Dynavox Group AB 5.38% of the capital sold short
- RaySearch Laboratories AB (publ) 4.96% of the capital sold short
- Aktiebolaget Electrolux 4.41% of the capital sold short
- AAK AB (publ) 4.31% of the capital sold short
- Hexatronic Group AB 3.77% of the capital sold short
- Mips AB 3.64% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Xvivo Perfusion Aktiebolag, source Finansinspektionen, data as at September 24, 2026, https://www.quivad.com/action/xvivo-perfusion-aktiebolag?page=3